세계의 ISH(In Situ Hybridization) 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 제품 유형별, 기술별, 용도별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)
In Situ Hybridization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technology, By Application, By End User, By Region and Competition, 2020-2030F
세계의 ISH(In Situ Hybridization) 시장은 2024년에 18억 8,000만 달러로 평가되었고, 2030년에는 29억 1,000만 달러에 이를 것으로 예측되며, 예측 기간 동안 CAGR 7.54%로 성장할 전망입니다.
ISH는 조직 샘플 내 특정 핵산 서열을 정확히 검출할 수 있는 능력으로 인해 분자 진단 및 생물의학 연구 분야에서 필수적인 도구로 점점 더 인정받고 있습니다. 질병의 정확한 조기 진단에 대한 수요, 특히 종양학과 유전적 질환 분야에서 증가하고 있습니다. ISH는 유전자 발현 패턴과 변이를 상세히 시각화할 수 있어 맞춤형 의료 전략의 핵심 요소로 자리매김하고 있습니다.
| 시장 개요 |
| 예측 기간 |
2026-2030년 |
| 시장 규모(2024년) |
18억 8,000만 달러 |
| 시장 규모(2030년) |
29억 1,000만 달러 |
| CAGR(2025-2030년) |
7.54% |
| 급성장 부문 |
세포 유전학 |
| 최대 시장 |
북미 |
자동화 염색 플랫폼과 고해상도 이미징과 같은 기술 혁신은 ISH의 사용 편의성과 신뢰성을 향상시켜 임상 실험실 및 연구 기관에서의 광범위한 채택을 촉진하고 있습니다. 다중 검출 기술과 개선된 프로브 설계는 여러 유전적 표적을 동시에 검출할 수 있도록 하여 진단 효율성과 환자 예후를 개선하고 있습니다. 정밀 의학이 계속 발전함에 따라 ISH는 맞춤형 치료 옵션 제공에서의 중요성이 확대되며, 현대 진단 및 신약 개발에서의 역할을 강화하고 있습니다
시장 성장 촉진요인
암 및 유전자 질환의 발생률 증가
주요 시장 과제
ISH 기술 및 시약의 높은 비용
주요 시장 동향
맞춤형 의료와의 통합
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 ISH(In Situ Hybridization) 시장 전망
- 시장 규모와 예측
- 시장 점유율 및 예측
- 제품 유형별(기기, 소모품 및 액세서리, 소프트웨어, 서비스)
- 기술별(형광 ISH(In Situ Hybridization), 발색 ISH(In Situ Hybridization))
- 용도별(암, 세포 유전학, 감염증, 신경과학, 면역학, 기타)
- 최종 사용자별(병원 및 진단연구소, 학술연구기관, 제약 및 생명 공학 기업, 계약 연구 기관, 기타)
- 기업별(2024년)
- 지역별
- 시장 맵
제6장 북미의 ISH(In Situ Hybridization) 시장 전망
- 시장 규모와 예측
- 시장 점유율 및 예측
- 북미 : 국가별 분석
제7장 유럽의 ISH(In Situ Hybridization) 시장 전망
- 시장 규모와 예측
- 시장 점유율 및 예측
- 유럽 : 국가별 분석
제8장 아시아태평양의 ISH(In Situ Hybridization) 시장 전망
- 시장 규모와 예측
- 시장 점유율 및 예측
- 아시아태평양 : 국가별 분석
제9장 남미의 ISH(In Situ Hybridization) 시장 전망
- 시장 규모와 예측
- 시장 점유율 및 예측
- 남미 : 국가별 분석
제10장 중동 및 아프리카의 ISH(In Situ Hybridization) 시장 전망
- 시장 규모와 예측
- 시장 점유율 및 예측
- 중동 및 아프리카 : 국가별 분석
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
제11장 시장 역학
제12장 시장 동향과 발전
제13장 Porter's Five Forces 분석
- 업계 내 경쟁
- 신규 진입의 가능성
- 공급자의 힘
- 고객의 힘
- 대체품의 위협
제14장 경쟁 구도
- Thermo Fisher Scientific, Inc.
- Abbott Laboratories Inc.
- PerkinElmer, Inc.
- Bio View Ltd.
- Agilent Technologies, Inc.
- Merck KGaA
- Bio:Rad Laboratories, Inc.
- Biotechne Corporation
- F. Hoffmann Roche AG
- Biocare Medical LLC
제15장 전략적 제안
제16장 기업 소개와 면책사항
HBR
The Global In Situ Hybridization (ISH) Market was valued at USD 1.88 Billion in 2024 and is projected to reach USD 2.91 Billion by 2030, growing at a CAGR of 7.54% during the forecast period. ISH is increasingly recognized as a vital tool in molecular diagnostics and biomedical research due to its capability to precisely detect specific nucleic acid sequences within tissue samples. The demand for accurate and early detection of diseases, particularly in oncology and genetic disorders, is driving market growth. ISH enables detailed visualization of gene expression patterns and mutations, making it a cornerstone in personalized medicine strategies.
| Market Overview |
|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 1.88 Billion |
| Market Size 2030 | USD 2.91 Billion |
| CAGR 2025-2030 | 7.54% |
| Fastest Growing Segment | Cytogenetics |
| Largest Market | North America |
Technological innovations such as automated staining platforms and high-resolution imaging are enhancing the usability and reliability of ISH, facilitating broader adoption in clinical laboratories and research institutions. Developments in multiplex assays and improved probe designs are enabling simultaneous detection of multiple genetic targets, improving diagnostic efficiency and patient outcomes. As precision medicine continues to advance, ISH's relevance in delivering targeted treatment options is expanding, strengthening its role in modern diagnostics and drug development.
Key Market Drivers
Rising Incidence of Cancer and Genetic Disorders
The increasing global burden of cancer and genetic diseases is a primary growth driver for the In Situ Hybridization market. According to the World Health Organization, cancer accounted for approximately 20 million new cases and 9.7 million deaths in 2022. Lung, breast, and colorectal cancers were among the most prevalent. These rising figures underscore the need for accurate molecular diagnostic tools that can provide specific and early detection. ISH, particularly Fluorescent In Situ Hybridization (FISH), plays a critical role in identifying genetic abnormalities, gene fusions, and chromosomal rearrangements within tissue samples, aiding in diagnosis, prognosis, and treatment planning.
Key Market Challenges
High Cost of ISH Technology and Reagents
The adoption of ISH techniques faces a significant hurdle due to the high costs associated with equipment and consumables. Advanced instruments such as hybridization systems and imaging platforms require substantial investment, which can be restrictive for smaller laboratories and facilities in developing regions. Additionally, reagents including specialized probes and buffers contribute to the overall expense, making frequent use of ISH less feasible in cost-sensitive healthcare environments. These cost barriers may limit the accessibility of high-precision diagnostics, particularly where budget constraints impact healthcare delivery.
Key Market Trends
Integration with Personalized Medicine
A notable trend shaping the ISH market is its growing integration into personalized medicine. ISH techniques, especially FISH, are being leveraged to detect genetic mutations and biomarkers that inform individualized treatment regimens. This alignment with precision healthcare is particularly prominent in oncology, where ISH supports targeted therapies by identifying specific molecular features of tumors. Companion diagnostics utilizing ISH allow clinicians to tailor treatments based on a patient's genetic profile, enhancing therapeutic efficacy and minimizing adverse effects. This synergy with precision medicine is reinforcing the value of ISH as a diagnostic standard in both clinical and research settings.
Key Market Players
- Thermo Fisher Scientific, Inc.
- Abbott Laboratories Inc.
- PerkinElmer, Inc.
- Bio View Ltd.
- Agilent Technologies, Inc.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Biotechne Corporation
- F. Hoffmann Roche AG
- Biocare Medical LLC
Report Scope:
In this report, the Global In Situ Hybridization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
In Situ Hybridization Market, By Product:
- Instruments
- Consumables & Accessories
- Software
- Services
In Situ Hybridization Market, By Technology:
- Fluorescent In Situ Hybridization
- Chromogenic In Situ Hybridization
In Situ Hybridization Market, By Application:
- Cancer
- Cytogenetics
- Infectious Diseases
- Neuroscience
- Immunology
- Others
In Situ Hybridization Market, By End User:
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Others
In Situ Hybridization Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global In Situ Hybridization Market.
Available Customizations:
Global In Situ Hybridization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global In Situ Hybridization Market Outlook
- 5.1. Market Size & Forecast
- 5.2. Market Share & Forecast
- 5.2.1. By Product (Instruments, Consumables & Accessories, Software, Services)
- 5.2.2. By Technology (Fluorescent In Situ Hybridization, Chromogenic In Situ Hybridization)
- 5.2.3. By Application (Cancer, Cytogenetics, Infectious Diseases, Neuroscience, Immunology, Others)
- 5.2.4. By End User (Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Others)
- 5.2.5. By Company (2024)
- 5.2.6. By Region
- 5.3. Market Map
6. North America In Situ Hybridization Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Technology
- 6.2.3. By Application
- 6.2.4. By End User
- 6.2.5. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States In Situ Hybridization Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Product
- 6.3.1.2.2. By Technology
- 6.3.1.2.3. By Application
- 6.3.1.2.4. By End User
- 6.3.2. Mexico In Situ Hybridization Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Product
- 6.3.2.2.2. By Technology
- 6.3.2.2.3. By Application
- 6.3.2.2.4. By End User
- 6.3.3. Canada In Situ Hybridization Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Product
- 6.3.3.2.2. By Technology
- 6.3.3.2.3. By Application
- 6.3.3.2.4. By End User
7. Europe In Situ Hybridization Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Technology
- 7.2.3. By Application
- 7.2.4. By End User
- 7.2.5. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. France In Situ Hybridization Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Product
- 7.3.1.2.2. By Technology
- 7.3.1.2.3. By Application
- 7.3.1.2.4. By End User
- 7.3.2. Germany In Situ Hybridization Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Product
- 7.3.2.2.2. By Technology
- 7.3.2.2.3. By Application
- 7.3.2.2.4. By End User
- 7.3.3. United Kingdom In Situ Hybridization Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Product
- 7.3.3.2.2. By Technology
- 7.3.3.2.3. By Application
- 7.3.3.2.4. By End User
- 7.3.4. Italy In Situ Hybridization Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Product
- 7.3.4.2.2. By Technology
- 7.3.4.2.3. By Application
- 7.3.4.2.4. By End User
- 7.3.5. Spain In Situ Hybridization Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Product
- 7.3.5.2.2. By Technology
- 7.3.5.2.3. By Application
- 7.3.5.2.4. By End User
8. Asia-Pacific In Situ Hybridization Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Technology
- 8.2.3. By Application
- 8.2.4. By End User
- 8.2.5. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China In Situ Hybridization Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Product
- 8.3.1.2.2. By Technology
- 8.3.1.2.3. By Application
- 8.3.1.2.4. By End User
- 8.3.2. India In Situ Hybridization Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Product
- 8.3.2.2.2. By Technology
- 8.3.2.2.3. By Application
- 8.3.2.2.4. By End User
- 8.3.3. South Korea In Situ Hybridization Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Product
- 8.3.3.2.2. By Technology
- 8.3.3.2.3. By Application
- 8.3.3.2.4. By End User
- 8.3.4. Japan In Situ Hybridization Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Product
- 8.3.4.2.2. By Technology
- 8.3.4.2.3. By Application
- 8.3.4.2.4. By End User
- 8.3.5. Australia In Situ Hybridization Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Product
- 8.3.5.2.2. By Technology
- 8.3.5.2.3. By Application
- 8.3.5.2.4. By End User
9. South America In Situ Hybridization Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Technology
- 9.2.3. By Application
- 9.2.4. By End User
- 9.2.5. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil In Situ Hybridization Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Product
- 9.3.1.2.2. By Technology
- 9.3.1.2.3. By Application
- 9.3.1.2.4. By End User
- 9.3.2. Argentina In Situ Hybridization Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Product
- 9.3.2.2.2. By Technology
- 9.3.2.2.3. By Application
- 9.3.2.2.4. By End User
- 9.3.3. Colombia In Situ Hybridization Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Product
- 9.3.3.2.2. By Technology
- 9.3.3.2.3. By Application
- 9.3.3.2.4. By End User
10. Middle East and Africa In Situ Hybridization Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Technology
- 10.2.3. By Application
- 10.2.4. By End User
- 10.2.5. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa In Situ Hybridization Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Product
- 10.3.1.2.2. By Technology
- 10.3.1.2.3. By Application
- 10.3.1.2.4. By End User
- 10.3.2. Saudi Arabia In Situ Hybridization Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Product
- 10.3.2.2.2. By Technology
- 10.3.2.2.3. By Application
- 10.3.2.2.4. By End User
- 10.3.3. UAE In Situ Hybridization Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Product
- 10.3.3.2.2. By Technology
- 10.3.3.2.3. By Application
- 10.3.3.2.4. By End User
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition (If Any)
- 12.2. Product Launches (If Any)
- 12.3. Recent Developments
13. Porters Five Forces Analysis
- 13.1. Competition in the Industry
- 13.2. Potential of New Entrants
- 13.3. Power of Suppliers
- 13.4. Power of Customers
- 13.5. Threat of Substitute Products
14. Competitive Landscape
- 14.1. Thermo Fisher Scientific, Inc.
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
- 14.2. Abbott Laboratories Inc.
- 14.3. PerkinElmer, Inc.
- 14.4. Bio View Ltd.
- 14.5. Agilent Technologies, Inc.
- 14.6. Merck KGaA
- 14.7. Bio-Rad Laboratories, Inc.
- 14.8. Biotechne Corporation
- 14.9. F. Hoffmann Roche AG
- 14.10. Biocare Medical LLC
15. Strategic Recommendations
16. About Us & Disclaimer
